论文部分内容阅读
目的探讨透明晶状体超声乳化吸出联合人工晶状体植入术治疗高度近视的临床治疗效果。方法对21例(37眼)高度近视行透明晶状体超声乳化联合人工晶状体植入术,观察术中、术后并发症以及术后视力改善情况,术后随访时间6～18月,平均12月。结果术后裸眼视力低于0.2者1眼,0.2～0.5者3眼,0.5～0.9者32眼,≥1.0者1眼,矫正视力0.2～0.5者2眼,0.5～0.9者28眼,≥1.0者7眼,较术前均有显著提高。术后4眼出现后囊轻度浑浊,未见黄斑水肿和视网膜脱离等并发症。结论通过仔细的术前检查,并掌握娴熟的手术技巧,透明晶状体超声乳化联合人工晶状体植入术能够作为治疗高度近视安全、有效的方法。
Objective To investigate the clinical effect of phacoemulsification combined with intraocular lens implantation for treatment of high myopia. Methods 21 cases (37 eyes) of high myopia were treated with phacoemulsification combined with intraocular lens implantation. The intraoperative and postoperative complications and postoperative visual acuity were observed. The follow - up time was 6 to 18 months (average 12 months). Results The postoperative uncorrected visual acuity was lower than 0.2 in 1 eye, 0.2 ~ 0.5 in 3 eye, 0.5 ~ 0.9 in 32 eye, ≥ 1.0 in 1 eye, corrected visual acuity in 0.2 ~ 0.5 in 2 eye, 0.5 ~ 0.9 in 28 eye, ≥ 1.0 7 eyes, compared with preoperative significantly increased. Posterior capsule 4 appeared mild cloudy, no macular edema and retinal detachment and other complications. Conclusion Through careful preoperative examination and mastery of skilled surgical techniques, transparent phacoemulsification and intraocular lens implantation can be used as a safe and effective method for the treatment of high myopia.